CA-GENOME RX INC.

From the company

Ca-Genome Rx leverages ultra-low-cost genomic and transcriptomic sequencing paired with proprietary genomic biomarkers and advanced machine learning tailored for genomics data. Its mission is to empower oncologists and patients with precise, actionable insights that optimize treatment decisions and enhance survival rates and outcomes in the battle against cancer. The company focuses on low-cost omics-based precision oncology and proprietary biomarkers such as Intragenic Rearrangement Burden (IGR) and Tumor-Associated Antigen Burden (TAB).